Integrated Analysis of Bortezomib-Lenalidomide-Dexamethasone vs Bortezomib-Thalidomide-Dexamethasone in Transplant-Eligible Newly Diagnosed Myeloma

Affiliation auteurs!!!! Error affiliation !!!!
TitreIntegrated Analysis of Bortezomib-Lenalidomide-Dexamethasone vs Bortezomib-Thalidomide-Dexamethasone in Transplant-Eligible Newly Diagnosed Myeloma
Type de publicationJournal Article
Year of Publication2019
AuteursRosinol L, Hebraud B, Oriol A, Colin A-L, Tamayo RRios, Hulin C, Blanchard MJesus, Caillot D, Balari ASureda, Hernandez MT, Arnulf B, Mateos M-V, Macro M, San-Miguel J, Belhadj K, Lahuerta J-J, M. Garelik B, Blade J, Moreau P, Attal M
JournalCLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Volume19
PaginationE1-E2
Date PublishedOCT
Type of ArticleMeeting Abstract
ISSN2152-2650
Mots-clésinduction therapy, newly diagnosed MM, RVD
DOI10.1016/j.clml.2019.09.002